Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
07/08/2009 | EP1536768B1 Biodegradable composition with prolonged release of an antitumour agent and preparation thereof |
07/08/2009 | EP1440962B1 Stabilized compositions of aqueous reduced coenzyme q solution |
07/08/2009 | EP1435918B1 Highly compressible ethylcellulose for tableting |
07/08/2009 | EP1432457B1 Sanitary napkins with hydrophobic lotions |
07/08/2009 | EP1171471B2 Enhanced gel strength methylcellulose |
07/08/2009 | EP1126826B9 Multiparticulate modified release composition of methylphenidate |
07/08/2009 | EP1009429B1 Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient |
07/08/2009 | EP0738142B1 Perfluorocarbons as anti-inflammatory agents |
07/08/2009 | CN101478958A Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant |
07/08/2009 | CN101478957A Disposable infusion device with linear peristaltic pump |
07/08/2009 | CN101478956A Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
07/08/2009 | CN101478955A Pellet formulation comprising colloidal silicon dioxide |
07/08/2009 | CN101478954A Stable mixture of corticosteroids |
07/08/2009 | CN101478953A Antimicrobial hand towel for touchless automatic dispensers |
07/08/2009 | CN101478952A Ropinirole-containing pharmaceutical compositions in the form of a gel, uses thereof |
07/08/2009 | CN101478951A Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
07/08/2009 | CN101478950A Aqueous suspensions of TMC278 |
07/08/2009 | CN101478949A VEGF antagonist formulations suitable for intravitreal administration |
07/08/2009 | CN101474169A Hydrogel eye plaster special for patient with general anesthesia |
07/08/2009 | CN101474168A Fenticonazole nitrate vaginal soft capsule and preparation method thereof |
07/08/2009 | CN101474167A Preparation method of estradiol capsule for vagina |
07/08/2009 | CN101474166A Cetirizine and pseudoephedrine sustained-release capsule and preparation method thereof |
07/08/2009 | CN101474165A Polynucleotide microcapsule for treating diseases of livestock and poultry and preparation method thereof |
07/08/2009 | CN101474164A Oral compound paclitaxel capsule and preparation method |
07/08/2009 | CN101474163A Lovastatin and niacin sustained-release preparation and preparation method thereof |
07/08/2009 | CN101474162A Preparation method of naproxen granule for direct tablet forming |
07/08/2009 | CN101474161A Nicorandil freeze-dried injection and preparation method thereof |
07/08/2009 | CN101474160A Oil in oil-oil in oil-water in oil method for preparing microballoons |
07/08/2009 | CN101474159A Creatine phosphate sodium microballoon lyophilized preparation and method for producing the same |
07/08/2009 | CN101474158A Preparation method of vitamin B6 granule for direct tablet forming |
07/08/2009 | CN101474157A Asiatic acid injectable sustained-release microballoons and preparation method thereof |
07/08/2009 | CN101474156A Vitamin C precursor liposome and preparation method thereof |
07/08/2009 | CN101474155A Lung-targeted medicine carrying precursor liposome for injection and method of use thereof |
07/08/2009 | CN101474154A 4-(1-phenethyl)-1,3-dihydroxy benzene liposome and preparation method thereof |
07/08/2009 | CN101474153A Epidermal growth factor nano lipid vector preparation for skin and preparation method thereof |
07/08/2009 | CN101474152A Mefloquine fat emulsion composition and method for preparing the same |
07/08/2009 | CN101474151A Alkannin microemulsion composition |
07/08/2009 | CN101474150A Stable alprostadil injection emulsion and preparation method thereof |
07/08/2009 | CN101474149A One-step emulsification method of inactivated vaccine |
07/08/2009 | CN101474148A Oral liquid sustained-release preparation containing codeine and chlorphenamine and preparation method thereof |
07/08/2009 | CN101474147A Cinepazide maleate injection and preparation method thereof |
07/08/2009 | CN101474146A Timolol maleate eye drops without bacteriostatic agent and preparation method thereof |
07/08/2009 | CN101474145A Compound sodium acetate injection |
07/08/2009 | CN101474144A Tetracaine hydrochloride lipidosome gel and preparation method thereof |
07/08/2009 | CN100509847C Crystalline tumor necrosis factor receptor 2 polypeptides |
07/08/2009 | CN100509843C Acid-modified arabinogalactan protein composition |
07/08/2009 | CN100509100C Spray drying & granulating method and apparatus |
07/08/2009 | CN100509060C Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a PLGA matrix |
07/08/2009 | CN100509056C Vaccines including as an adjuvant type 1 IFN and process related thereto |
07/08/2009 | CN100509054C Topical drug delivery using phosphatidylcholine |
07/08/2009 | CN100509053C Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
07/08/2009 | CN100509047C Combination of medication for treating hepatitis B and preparation method thereof |
07/08/2009 | CN100509042C Combination of medication for treating gastric disease and preparing method thereof |
07/08/2009 | CN100509022C Plaster for traumatic injuries |
07/08/2009 | CN100509020C Plaster for bone disease |
07/08/2009 | CN100509015C Combination of medication for treating gastric ulcer |
07/08/2009 | CN100509008C Shutongfang for killing pain and preparation and use thereof |
07/08/2009 | CN100508997C Korean pine kernel soft capsule and preparing method thereof |
07/08/2009 | CN100508993C Enterobacteria containing tablet |
07/08/2009 | CN100508988C Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
07/08/2009 | CN100508976C Orally dissolving films |
07/08/2009 | CN100508974C Transdermal patch for administering fentanyl |
07/08/2009 | CN100508966C Pharmaceutical preparation containing gabapentin |
07/08/2009 | CN100508965C Dosage forms having prolonged active ingredient release |
07/08/2009 | CN100508964C Patch |
07/08/2009 | CN100508963C Antimicrobial compositions |
07/08/2009 | CN100508960C Dermal system of two patches detachably secured to each other for providing therapy to an area of the body |
07/08/2009 | CN100508959C Hollow quick soluble film capsule |
07/08/2009 | CN100508958C Buckskin powder capsule and preparation method thereof |
07/08/2009 | CN100508957C Improved oral delivery of peptides |
07/08/2009 | CN100508956C Ganoderma spore tablet and preparation process thereof |
07/08/2009 | CN100508955C Effervesce tablet of American ginseng containing vitamin C and preparation method thereof |
07/08/2009 | CN100508954C Preparation process and prescription of oleum fructus bruceae containing microemulsion |
07/08/2009 | CN100508953C Superloaded liposomes for drug delivery |
07/08/2009 | CN100508952C Freezing-dried and non-freezing-dried hydroquinone mono-propionate beautifying effect nanometer emulsion and preparation method thereof |
07/08/2009 | CN100508951C Method of preparing transparent water dispersion type lycopene concentrated liquor |
07/08/2009 | CN100508950C Method for preparation of cross-linking hyaluronic acid sodium jelly glue implanted in eyes |
07/08/2009 | CN100508949C Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
07/07/2009 | USRE40839 Taxol treatment of cancer |
07/07/2009 | US7557128 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen |
07/07/2009 | US7556827 Implantable active ingredient depot comprising matrix of glyceryl-monooleate and at least one modifier molecule comprising 1,2-distearoyl-glycerophosphatidyl-ethanolamin-methyl-polyethylene glycol wherein matrix provides controlled release of active ingredient |
07/07/2009 | US7556826 Bioactive agent, a low molecular weight chitosan, and a negatively charged third component; the chitosan dominates on the nanoparticle surface; enhanced permeability for paracellular drug delivery; chewable composition |
07/07/2009 | US7556825 Method for promoting hair growth |
07/07/2009 | US7556824 Transdermal patch comprising hydralazine derivative antioxidant and isosorbide di- and/or mononitrate |
07/07/2009 | US7556823 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
07/07/2009 | US7556821 Delivery system having a microprojection member that includes a plurality of microprojections adapted to pierce through stratum corneum into underlying epidermis layer; improved pharmacokinetics can comprise increased bioavailability of the PTH-based agent; treatment of osteoporosis and bone fractures |
07/07/2009 | US7556814 Antigen containing an attenuated strain of human immunodeficient virus; using psoralen and ultraviolet radiation |
07/07/2009 | US7556799 removing potassium from the gastrointestinal tract with a potassium-binding polymer; an alpha-fluoroacrylic acid polymer, or a difluoromaleic acid polymer crosslinked with vinylsulfonic acid, acrylic acid, vinyl phosphonate, vinyl-1,1-bisphosphonate, vinyl sulfonate, vinyl-1,2-disulfonate, itaconic aci |
07/07/2009 | US7556798 Single, breath-activated step of delivering a drug to the pulmonary system by inhaling dry powder particles as carriers for adhered, adsorbed or chemically-combined bioactive agents; 50% of stored particle mass delivered; 5 milligrams of drug delivered; antiagglomerants; asthma; cyctic fibrosis |
07/07/2009 | US7556649 Methods and compositions for treating intervertebral disc degeneration |
07/07/2009 | US7556613 Array and method for dosing a hormone regulating blood sugar in a patient |
07/07/2009 | CA2566684C Pharmaceutical nitrones |
07/07/2009 | CA2519175C A method of treating a systemic disease |
07/07/2009 | CA2420712C Fast release cefuroxime axetil compositions |
07/07/2009 | CA2406790C Sustained release formulations |
07/07/2009 | CA2406119C Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
07/07/2009 | CA2400994C Radioactive therapeutic liposomes |
07/07/2009 | CA2388809C A topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
07/07/2009 | CA2382442C Pore structures for reduced pressure aerosolization |
07/07/2009 | CA2380128C Plasters containing 4-biphenylacetic acid |